India's Bajaj Healthcare hits over 9-month high

Bajaj Healthcare

18/11/2022 05:13

** Shares of pharmaceuticals co Bajaj Healthcare Ltd
 BAJH.NS  rise as much as 7.5% to 423.90 rupees, their highest
since Feb. 8
    ** Co on Friday said it has completed the United State Food
and Drug Administration's (USFDA) first ever pre-approval
inspection of its active pharmaceutical ingredient (API)
facility located at Vadodara, Gujarat
    ** Co says pre-approval inspection was completed with ZERO
483 observations - meaning no observed conditions or practices
that could be in violation of FDA norms
    ** BAJH posts sharpest intraday pct gain since Sept. 5 
    ** More than 514,000 shares traded as of 0502 GMT, 9.8X
their 30-day moving avg of 52,380 shares
    ** Shares down 4.7% YTD, as of last close
 (Reporting by Meenakshi Maidas in Bengaluru)
 ((meenakshi.maidas@thomsonreuters.com;))